comparemela.com

Page 6 - Lucas Vasques News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Singapore accepts Everest s NDA for IgA nephropathy treatment

The Singapore Health Sciences Authority (HSA) has accepted Everest Medicines’ new drug application (NDA) for Nefecon.

Kura Oncology, Inc (NASDAQ:KURA) Q4 2022 Earnings Call Transcript

Syneos Health, Inc (NASDAQ:SYNH) Q4 2022 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen. Welcome to the Syneos Health Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.